Alongside the free site, InLight Bio offers a weekly Science Briefing, a Deal Tracker and custom market & industry reports for teams that follow biomedical science and biopharma licensing closely, and asset partnering and BD introductions for under-partnered assets.
Subscriptions, report requests and questions: contact@
Engagement terms are agreed case by case; contact bd@
InLight Bio provides information and introductions only. It is not a broker-dealer, investment adviser or placement agent, and nothing on this site is an offer or solicitation to buy or sell any securities. Please do not send confidential information before an NDA is in place.
We source under-partnered clinical and preclinical assets worldwide and assess whether each one fits a straight license, a co-development deal or a new company (NewCo). For assets that fit, we help structure the transaction: rights and territory, upfront, equity, milestones and royalties, and the development plan. We make BD and investor introductions to US venture investors, company-creation firms, management teams and pharma partners. Confidential material is shared in tiers, starting with an anonymous teaser and moving to an NDA package only with the owner's approval.